Search research articles
Contact Us
Filters
Showing results (291-300 of 394) with videos related to
Page
of 40
Sort By:
Dermatology and Therapy
|
July 9, 2024
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
April W Armstrong, Tarannum Jaleel, Joseph F Merola, et al.
The Journal of Rheumatology
|
November 1, 2022
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, María Julia Cura, et al.
JAMA Dermatology
|
April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement
Joseph F Merola, Beth A Childs, Brooke R Bartley, et al.
JAMA Dermatology
|
August 20, 2025
Comparative Risk of Infection and Prevalence of Combination Targeted Therapy in Psoriatic Arthritis
Alexander Wu, Arianna Zhang, Yujia Guo, et al.
Dermatology and Therapy
|
May 30, 2024
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
April W Armstrong, Tarannum Jaleel, Joseph F Merola, et al.
Nature Reviews. Rheumatology
|
February 16, 2021
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study
Lourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, et al.
BMJ Open
|
February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes
Linnea Thorlacius, John R Ingram, Amit Garg, et al.
International Journal of Dermatology
|
December 10, 2020
Measuring fatigue: a meta-review
Myrela O Machado, Na-Young Cindy Kang, Felicia Tai, et al.
Clinical Rheumatology
|
June 6, 2024
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study
Christopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
August 16, 2024
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual Survey
Melissa P Zundell, Alexis R Ogdie-Beatty, Lourdes Perez-Chada, et al.
Page
of 40
Search research articles
Search
Showing results (291-300 of 394) with videos related to
Sort By:
Page
of 40
Dermatology and Therapy
|
July 9, 2024
Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
April W Armstrong, Tarannum Jaleel, Joseph F Merola, et al.
The Journal of Rheumatology
|
November 1, 2022
Treatment of Psoriasis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations
Kristina Callis Duffin, Luis Daniel Mazzuoccolo, María Julia Cura, et al.
JAMA Dermatology
|
April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement
Joseph F Merola, Beth A Childs, Brooke R Bartley, et al.
JAMA Dermatology
|
August 20, 2025
Comparative Risk of Infection and Prevalence of Combination Targeted Therapy in Psoriatic Arthritis
Alexander Wu, Arianna Zhang, Yujia Guo, et al.
Dermatology and Therapy
|
May 30, 2024
Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity
April W Armstrong, Tarannum Jaleel, Joseph F Merola, et al.
Nature Reviews. Rheumatology
|
February 16, 2021
Consensus terminology for preclinical phases of psoriatic arthritis for use in research studies: results from a Delphi consensus study
Lourdes M Perez-Chada, Rebecca H Haberman, Vinod Chandran, et al.
BMJ Open
|
February 22, 2017
Protocol for the development of a core domain set for hidradenitis suppurativa trial outcomes
Linnea Thorlacius, John R Ingram, Amit Garg, et al.
International Journal of Dermatology
|
December 10, 2020
Measuring fatigue: a meta-review
Myrela O Machado, Na-Young Cindy Kang, Felicia Tai, et al.
Clinical Rheumatology
|
June 6, 2024
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study
Christopher T Ritchlin, Philip J Mease, Wolf-Henning Boehncke, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
August 16, 2024
Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual Survey
Melissa P Zundell, Alexis R Ogdie-Beatty, Lourdes Perez-Chada, et al.
Page
of 40